{"id":47192,"date":"2022-08-11T15:01:58","date_gmt":"2022-08-11T13:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/tech-tackles-cancer-raises-more-than-320k-to-fight-pediatric-cancer\/"},"modified":"2022-08-11T15:01:58","modified_gmt":"2022-08-11T13:01:58","slug":"tech-tackles-cancer-raises-more-than-320k-to-fight-pediatric-cancer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/tech-tackles-cancer-raises-more-than-320k-to-fight-pediatric-cancer\/","title":{"rendered":"Tech Tackles Cancer Raises More Than $320K to Fight Pediatric Cancer"},"content":{"rendered":"
\n

\nDonations Made to St. Baldricks and One Mission at Recent Ceremony<\/i>\n<\/p>\n

BOSTON, Mass.–(BUSINESS WIRE)–#AI<\/a>–Hack\/Reduce, a non-profit focused on creating talent and technologies for Boston\u2019s big data-driven economy, today announced that more than $320,000 has been raised to fight pediatric cancer-related causes from its sixth annual Tech Tackles Cancer<\/a> (TTC) event.\n<\/p>\n

<\/a><\/p>\n

\n\u201cThe event was a tremendous success. When the Boston technology community comes together, great things can happen,\u201d said Christopher Lynch, founder of TTC. \u201cA sincere thank you to all of our performers, sponsors and donors. I\u2019m looking forward to building off of this momentum to do even greater things for charities that need our help.\u201d\n<\/p>\n

\nTTC 2022 was the first in-person event after a pandemic-driven hiatus of 2 years. Similar in format to previous years, the funds were raised with the support of 14 \u201cfeatured performers\u201d <\/a>who fundraised from their own networks, as well as through the generous participation of more than 20 corporate sponsors<\/a>. The fundraiser benefitted two Boston-area philanthropies supporting those affected by pediatric cancer, St. Baldricks<\/a> and One Mission<\/a>. The donations were made to the organizations at a recent ceremony held at Diamond Sponsor AtScale\u2019s Boston office.\n<\/p>\n

\n\u201cThe St. Baldrick\u2019s Foundation is grateful for the support of Tech Tackles Cancer. As a volunteer and donor-powered charity committed to supporting the most promising research to find cures for childhood cancers, the generosity of everyone involved in hosting the event is crucial to funding pediatric research grants. Every energetic performer, representing so many different tech companies, truly had an impact that night – and the outcome is more research will be funded that gives so many kids hope for long and healthy lives!\u201d added Kathleen Ruddy, CEO of the St. Baldrick\u2019s Foundation.\n<\/p>\n

\nHeld at the Sinclair in Cambridge, MA<\/a>, the event was structured as a \u201cbattle of the technology rockstars,\u201d where Boston-area technology executives would live out their rock-and-roll dreams on stage, backed by a professional band. All performers pledged to raise money for the cause, with awards given for the favorite performances and most funds raised.\n<\/p>\n

\n\u201cThe Infinidat team was a huge supporter of Tech Tackles Cancer 2022. Ken Steinhardt, our Field CTO, raised money as a performer. Dan Pearl, our head of revenue ops, was on the executive committee. Many of our employees donated – and our whole team watched the development of the event as it grew in scope and impact,\u201d said Eric Herzog, CMO of Infinidat. \u201cThe power of the technology community to make a meaningful difference in the lives of those who need it is incredible, and TTC is a phenomenal program to harness this power. We are looking forward to next year!\u201d\n<\/p>\n

\nThe awards handed out were:\n<\/p>\n